Human Mesenchymal Stem Cells found to favour the survival of tuberculosis bacteria, instead of fighting it, shows a recent study.
Human Mesenchymal Stem Cells found to favour the survival of tuberculosis bacteria, instead of fighting it, shows a recent study.
In a recent study, researchers at the Indian Institute of Science (IISc), Bengaluru, and Christian Medical College, Vellore, have developed a novel, inexpensive and easy-to-use device to detect tuberculosis.
Researchers find familial dissimilarities in proteins from two species of Mycobacterium.
In 2018, around 1.5 million people died from tuberculosis (TB) — an infectious disease that mainly affects the lungs. A major obstacle in the clinical treatment of TB is the long therapy time required to clear the infection. An infected patient needs to take antibiotics for over 6 to 9 months to prevent a relapse — a duration so long that many discontinue their medications.